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A case of chickenpox with complication of 
post-infectious thrombocytopenic purpura
Smiyan Oleksandr Ivanovich, Bynda Tetiana Parfenivna,  
Smiian Kateryna Oleksandrivna, Manko Yulia Anatolievna*
Idiopathic thrombocytopenic purpura is a rare but serious complication of chickenpox. The purpose of this report is to describe a 
case of varicella-related complications of post-infectious idiopathic thrombocytopenic purpura, with a brief review of the literature 
related to varicella-related haemorrhages, and to determine the specific features of treatment of such children. A 5-year-old unvac-
cinated boy was admitted to the hospital for infectious diseases on the 7th day of illness. It was found that on the 5th day of the disease 
onset, crusts and haemorrhagic rashes measuring 10x10 mm appeared on the skin of the child. Then, on the 6th day of the disease, 
multiple blood exudates of various shapes and sizes (from 1 mm to 30 mm in diameter) and two episodes of nose bleeding appeared. 
Blood test showed a platelet count of 9.0x109/L. Intravenous immunoglobulin was administered to the child for treatment. The child 
was discharged from the hospital in a satisfactory condition on the 6th day of treatment. There was no recurrence of the disease 
within 1 year after the illness. Thus, taking into account the positive effect of the use of intravenous immunoglobulin in post-infec-
tious idiopathic thrombocytopenic purpura, it can be recommended to be used in this condition. However, additional studies are 
needed to clarify the mechanisms of development of this complication. It is possible to prevent the disease and its serious conse-
quences by vaccinating children against chickenpox.
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InTrOduCTIOn
Chickenpox is a self-limiting benign disease; occasionally, it 
may cause complications (1-3). the most common infec-
tious complication of varicella is secondary bacterial infec-
tion of the skin, most often by staphylococcus or streptococ-
cus species. the most common extracutaneous site of in-
volvement is the central nervous system (CNS), i.e. acute 
cerebellar ataxia, aseptic meningitis and encephalitis. trans-
verse myelitis, Guillain-barré syndrome and reye’s syndrome 
can also occur. Varicella pneumonia is the most serious 
complication following varicella infection, developing more 
commonly in adults (up to 20% of cases) than in children. 
Other rare complications include myocarditis, corneal in-
volvement, arthritis, bleeding diathesis, acute glomerulone-
phritis and hepatitis (4). the incidence of idiopathic throm-
bocytopenic purpura (ItP) among children with varicella is 
estimated to 1:25,000, and ItP associated with varicella ac-
counts for 1.9% of paediatric ItP cases (5). the cause of com-
plications has been postulated as either direct viral invasion 
or through an immune-mediated allergic mechanism. most 
pathological studies have shown that it is more likely to be 
allergy-mediated injury (1).
We present a previously healthy child suffering from chick-
enpox with thrombocytopenic purpura that was managed 
successfully with intravenous immunoglobulin.
CASe rePOrT
a 5-year-old child was admitted to the infectious diseases 
hospital on the 7th day after the onset of chickenpox. the 
diagnosis was chickenpox, recovery period. Complications: 
idiopathic thrombocytopenic purpura, nasal bleeding, 1st 
degree anaemia.
124
IvanovIch So, olekSandrIvna Shk, ParfenIvna BT, anaTolIevna MY. a caSe of chIckenPox wITh coMPlIcaTIon… Paediatr Croat. 2019;63:123-5
according to the history, the child was not vaccinated 
against chickenpox. the course of the disease was of mod-
erate severity (temperature 38.5 °C, rash spread on the skin 
and mucous membranes). the child was treated on an out-
patient basis (brilliant green locally). On the 5th day of the 
disease, 10x10 mm single haemorrhages appeared on the 
skin of the body and limbs; on the 6th day, there were mul-
tiple blood effusions of various shapes and sizes (from 1 
mm to 30 mm in diameter) and nasal bleeding was noted 
twice. Clinical blood analysis showed platelet count 
9.0x109/L. during hospitalization the clinical blood analysis 
showed the following results: haemoglobin 9.7 g/dL, red 
blood cell (rbC) count 3.3x1012/L, white blood cell (WbC) 
count 10.3x109/L, eosinophils 2%, stab neutrophils 2%, 
 segmented neutrophils 71%, lymphocytes 24%, monocytes 
1%, erythrocyte sedimentation rate (ESr) 30 mm/h, platelet 
count 6х109/L. there were no changes in biochemical 
blood analysis and duration of bleeding. Liver function and 
renal function tests were normal. the child’s coagulation 
profile: bleeding time five minutes, clotting time six min-
utes, thrombin time 16 seconds, serum fibrinogen level 
210 mg/dL.
due to the repeated nasal bleeding, the child was treated 
with anterior and posterior nasal packing in the hospital. 
the following treatment was prescribed: intravenous im-
munoglobulin 8 mL/kg per day for 4 days.
as a result of treatment, nasal bleeding stopped on the 2nd 
day, there was no new rash on the skin, and platelets began 
to increase gradually and reached the level of 198x109/L on 
clinical blood analysis on the 4th day of treatment.
the child was discharged from the hospital in satisfactory 
condition and under supervision of haematologist and fam-
ily physician on the 6th day. at 1-year follow up, he was fine, 
without any complaints and with normal clinical blood 
tests.
a written informed consent was obtained from the patient’s 
parents.
dISCuSSIOn
Our case demonstrates that thrombocytopenia is one of 
the rare but well-known complications of primary varicella 
zoster infection and its early diagnosis is essential for appro-
priate management of the patient. although various mech-
anisms have been implicated in its pathogenesis, including 
decreased bone marrow production of platelets, dissemi-
nated intravascular coagulation and virally induced platelet 
aggregation followed by phagocytosis or lysis, the main 
mechanism implicated is immune-mediated platelet de-
struction (6). today, it is proved that the mechanism of post-
varicella purpura fulminant is thought to be due to devel-
opment of antiprotein S antibodies. these antibodies lead 
to acquired transient severe protein S deficiency, which re-
sults in disseminated intravascular coagulation and micro-
vascular thrombosis (7). treatment is symptomatic, includ-
ing fresh frozen plasma to treat protein depletion, anti-
thrombin III and heparinisation against thrombus formation, 
and anti-inflammatory drugs (steroids) (8). However, new 
therapies such as prostaglandin E intravenously and prosta-
cyclin are being introduced (3). In addition, successful use of 
both corticosteroids and intravenous immunoglobulin has 
been reported, the former past the incubation period of 
chickenpox because corticosteroids at doses ≥0.5 mg/kg/
day during the incubation period of varicella can lead to de-
velopment of visceral varicella (6). Other studies also found 
early platelet count recovery within three months of intra-
venous immunoglobulin treatment, predicting a short du-
ration of disease and favourable outcome in children with 
newly diagnosed ItP (9).
although thrombocytopenia can be a finding of severe 
varicella, isolated thrombocytopenia in otherwise healthy 
children who are recovering from chickenpox has an excel-
lent prognosis (6). this complication could be avoided by to 
anti-varicella zoster virus vaccination (10, 11).
COnCluSIOn
the resulting positive effect of intravenous immunoglobu-
lin for post-infectious ItP allows us to recommend its use in 
this state. However, further research is needed to clarify the 
mechanisms of development of this complication. In con-
clusion, taking into account the availability of various treat-
ment approaches, research on this type of chickenpox will 
be very interesting and useful for the practitioner.
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S a Ž E t a K
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Idiopatska trombocitopenična purpura je rijetka, ali ozbiljna komplikacija vodenih kozica. Namjera ovoga prikaza je opisati slučaj s 
vodenim kozicama povezane komplikacije postinfektivne idiopatske trombocitopenične purpure, uz kratak pregled literature o krva-
renjima povezanim s vodenim kozicama te utvrditi specifične značajke liječenja takve djece. Petogodišnji necijepljeni dječak primljen 
je u bolnicu za zarazne bolesti 7. dana bolesti. Utvrđeno je da su se kraste i hemoragični osip veličine 10x10 mm pojavili na djetetovoj 
koži 5. dana od nastupa bolesti. Potom se 6. dana bolesti pojavilo više krvnih eksudata raznih oblika i veličina (promjera od 1 mm do 
30 mm) i krvarenje iz nosa u dva navrata. Krvne pretrage pokazale su broj trombocita od 9,0x109/L. Dijete je liječeno intravenskim 
imunoglobulinom. Dijete je otpušteno iz bolnice 6. dana liječenja u zadovoljavajućem stanju. Nije bilo recidiva bolesti u godinu dana 
od nastupa bolesti s komplikacijama. Stoga, uzimajući u obzir pozitivan učinak primjene intravenskog imunoglobulina u liječenju 
postinfektivne idiopatske trombocitopenične purpure, njegova se primjena može preporučiti za ovo stanje. Međutim, daljnja istraži-
vanja su potrebna kako bi se razjasnili mehanizmi razvoja ove komplikacije. Vodene kozice i njihove ozbiljne posljedice moguće je 
spriječiti cijepljenjem djece protiv ove bolesti.
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